On site event
Paris Colon Cancer Congress 2026
Overview
Event Highlights
- Uniting colorectal cancer specialists, multidisciplinary care teams, researchers, and patient advocates to advance evidence-based and patient-centered care.
- Highlighting innovation across early-onset, localized, and metastatic colorectal cancer, including immunotherapy, biomarkers, treatment sequencing, and survivorship.
- Giving international experts and patients a platform to share perspectives, debate challenging clinical areas, and improve colorectal cancer outcomes worldwide.
Date / Time
Dec 10, 2026 – Dec 12, 2026
Save to
The Paris Colon Cancer Congress 2026 (P3C) is an international congress dedicated to advancing the multidisciplinary management of colorectal cancer. It will bring together oncologists, surgeons, researchers, healthcare professionals, patient advocates, and leaders to discuss scientific developments and practical challenges in colorectal cancer care.
The programme will address early-onset, localized, and metastatic colorectal cancer, immunotherapy, biomarker-driven treatment, survivorship, quality of life, and multidisciplinary decision-making.
Organized by the Young Oncologist in GI Group – Europe, part of the OncoDaily ecosystem, P3C will provide a platform for international experts and patients to share experience, debate challenging areas, and discuss ways to improve access, communication, and outcomes.
Scientific Leadership

Julien Taieb – France
Professor of Gastroenterology and Gastrointestinal Oncology, Université Paris Cité
Head, Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, AP-HP
Member, Institut du Cancer Paris CARPEM
Founder, AGEO French Research Group on Gastrointestinal Tumors

Annalice Gandini – France
Medical Oncologist and Researcher, Centre de Recherche des Cordeliers, Paris
Researcher, Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou
PhD Researcher in Integrative and Translational Biology, Université Paris Cité
Researcher, SIRIC CARPEM Comprehensive Cancer Center

Amalya Sargsyan – Armenia
Amalya Sargsyan, MD, MSc
Medical Oncologist, Adult Solid Tumors and Chemotherapy Clinic, Yeolyan Hematology and Oncology Center
Head, Sarcoma Service, D’Clinic
Vice President, Research & Intelligence, OncoDaily
Adjunct Assistant Professor, Yerevan State Medical University
Research Physician, Immune Oncology Research Institute (IMMONC)
Founder, Young Oncology Group of Armenia

Francisco Javier Ros – Spain
Medical Oncologist, Department of Medical Oncology, Vall d’Hebron University Hospital
Clinical Investigator, Vall d’Hebron Institute of Oncology (VHIO)
Member, Gastrointestinal Tract Tumours Group, VHIO
Colon Cancer Team, VHIO
Scientific Leadership

Julien Taieb – France
Professor of Gastroenterology and Gastrointestinal Oncology, Université Paris Cité
Head, Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, AP-HP
Member, Institut du Cancer Paris CARPEM
Founder, AGEO French Research Group on Gastrointestinal Tumors

Annalice Gandini – France
Medical Oncologist and Researcher, Centre de Recherche des Cordeliers, Paris
Researcher, Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou
PhD Researcher in Integrative and Translational Biology, Université Paris Cité
Researcher, SIRIC CARPEM Comprehensive Cancer Center

Amalya Sargsyan – Armenia
Amalya Sargsyan, MD, MSc
Medical Oncologist, Adult Solid Tumors and Chemotherapy Clinic, Yeolyan Hematology and Oncology Center
Head, Sarcoma Service, D’Clinic
Vice President, Research & Intelligence, OncoDaily
Adjunct Assistant Professor, Yerevan State Medical University
Research Physician, Immune Oncology Research Institute (IMMONC)
Founder, Young Oncology Group of Armenia

Francisco Javier Ros – Spain
Medical Oncologist, Department of Medical Oncology, Vall d’Hebron University Hospital
Clinical Investigator, Vall d’Hebron Institute of Oncology (VHIO)
Member, Gastrointestinal Tract Tumours Group, VHIO
Colon Cancer Team, VHIO
Session Chairs

Jenny Seligmann – United Kingdom
Professor of Gastrointestinal Oncology, University of Leeds
Consultant Medical Oncologist, Leeds Teaching Hospitals NHS Trust / St James’s University Hospital
Chief Investigator, International FOxTROT Trial Platform
Co-Lead, CRUK CRC-STARS Translational Programme
Faculty Member, ESMO

Michel Ducreux – France
Professor of Oncology, Université Paris-Saclay
Head, Digestive Oncology Department, Gustave Roussy
Chair, Digestive Tract Oncology Committee, Gustave Roussy
Head, Clinical Trials Committee, WIN Consortium
Co-Chair, ESMO Congress on Gastrointestinal Cancers

Airazat Kazaryan – Norway
Consultant Surgeon / Senior Consultant, Department of Surgery, Østfold Hospital Trust
Senior Consultant, Department of Gastrointestinal and Paediatric Surgery, Oslo University Hospital
Deputy Leader, Surgical Research Group, Østfold Hospital Trust
Affiliated Surgeon, Department of Surgery, Yerevan State Medical University after M. Heratsi
Norway

Eric Van Cutsem – Belgium
Professor Emeritus with Formal Duties, Faculty of Medicine, KU Leuven
Gastroenterologist and Digestive Oncologist, UZ Leuven
Head, Clinical Digestive Oncology Laboratory, Leuven Cancer Institute
Member, KU Leuven Cancer Institute (LKI)
President, Belgian Foundation against Cancer
Medical Director & Co-Founder, Digestive Cancers Europe

Gertjan Rasschaert – Belgium
Gastroenterologist and Digestive Oncologist, UZ Leuven
Staff Member, Department of Gastroenterology and Hepatology, UZ Leuven
Academic Staff, Digestive Oncology, KU Leuven
PhD Researcher, KU Leuven

Sabine Tejpar – Belgium
Professor, Faculty of Medicine, KU Leuven
Gastroenterologist and Digestive Oncologist, UZ Leuven
Head, Digestive Oncology, KU Leuven
Head, Molecular Genetics of Colorectal Tumors, KU Leuven
Member, KU Leuven Cancer Institute (LKI)
Member, KU Leuven Institute for Single Cell Omics (LISCO)

Claire Gallois – France
Gastroenterologist and Digestive Oncologist, Hôpital Européen Georges-Pompidou, AP-HP
Faculty Member, Université Paris Cité
Researcher, Centre de Recherche des Cordeliers, INSERM
Member, Institut du Cancer Paris CARPEM / SIRIC CARPEM Comprehensive Cancer Center
Speakers
About the Congress
The Paris Colon Cancer Congress 2026 (P3C) is an international congress focused on advancing multidisciplinary and patient-centered colorectal cancer care. The program will cover early-onset, localized, and metastatic disease, immunotherapy, biomarkers, treatment sequencing, survivorship, quality of life, equity, and access to care.
Through expert sessions, clinical debates, multidisciplinary discussions, and patient perspectives, P3C aims to support practical strategies that improve colorectal cancer care and outcomes worldwide.
Who Should Attend?
P3C is designed for oncologists, surgeons, gastroenterologists, pathologists, researchers, oncology nurses, pharmacists, patient advocates, healthcare leaders, and other professionals involved in colorectal cancer care and research.
Why To Attend?
Participants will gain practical insights into current standards, emerging evidence, and challenging areas of colorectal cancer management. The congress will also offer opportunities to learn from international experts, multidisciplinary teams, and patient representatives.
Partnership Opportunities
Partnership & Collaboration Opportunities
Shushan Hovsepyan
Senior Vice President, OncoDaily
Email: shushan.hovsepyan@oncodaily.com
Phone: +1 571 775 9710
Event-Related Inquiries
Inessa Mkhitaryan
Head of Global Events, OncoDaily
Email: inessa.mkhitaryan@oncodaily.com
General Inquiries
Email: info@oncodaily.com
News & Updates
No updates yet.








